How Pharma Companies Use International Arbitration to Resolve Costly Disputes

Over the last few years, there has been an immense uptick in the number of life sciences disputes resolved through international arbitration, suggesting its increasing popularity when compared to the expense and potential reputational harm of United States district court litigation.

Our discussion covers:

• A case study in which a pharmaceutical company collaborated with Pillsbury and a litigation funder in enforcing its rights against a commercial distributor who breached a co-development agreement.
• How international arbitration works and how a claimant can take advantage of this unique process.
• An assessment of the potential damages issues on behalf of the claimant.
• An introduction to litigation funding and the criteria that a litigation funder relies upon when funding an arbitration.